FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4451011000001101: Viramune 200mg tablets (Boehringer Ingelheim Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18122701000001110 Viramune 200mg tablets (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18122801000001118 Viramune 200mg tablets (Boehringer Ingelheim Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Is a Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has active ingredient Nevirapine false Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Is a Viramune true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Nevirapine true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Viramune 200mg tablets (Boehringer Ingelheim Ltd) 60 tablet 6 x 10 tablets Is pack of False Viramune 200mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) 60 tablet 6 x 10 tablets Has AMP True Viramune 200mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier
Viramune 200mg tablets (Boehringer Ingelheim Ltd) 14 tablet 2 x 7 tablets Has AMP True Viramune 200mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start